Peritoneal mesothelial hyperplasia associated with gynaecological disease: A potential diagnostic pitfall that is commonly associated with endometriosis

Journal of Clinical Pathology

Volumn 64, Issue 4, 2011, Pages 313-318

  Oparka, Richard ^a   McCluggage, W Glenn ^b   Herrington, C Simon ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; CD34 ANTIGEN; CYTOKERATIN 5; CYTOKERATIN 6; ESTROGEN RECEPTOR; WT1 PROTEIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOSARCOMA; CELL INVASION; CELL PROLIFERATION; CELL TYPE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOCHEMISTRY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE GENITAL TRACT TUMOR; FLORID PERITONEAL MESOTHELIAL HYPERPLASIA; FOLLICLE CYST; GYNECOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH VESSEL; MENORRHAGIA; MESOTHELIUM CELL; MORPHOLOGY; OVARY ABSCESS; OVARY DISEASE; OVARY METASTASIS; OVARY TUMOR; PERITONEUM MESOTHELIOMA; PRIORITY JOURNAL; PSAMMOMA BODY; SALPINGOOOPHORECTOMY; SQUAMOUS CELL CARCINOMA; TISSUE CHARACTERIZATION; TUBOOVARIAN ABSCESS;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIOSIS; EPITHELIUM; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PERITONEAL NEOPLASMS; PERITONEUM; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79953070098     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.086074     Document Type: Article

References (24)

1. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol 2002;55:662-8. (Pubitemid 34970087)
2. Ordóñez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003;27:1031-51. (Pubitemid 36909525)
3. Ordóñez NG. Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med 2005;129:1407-14. (Pubitemid 41587015)
4. Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40:237-44. (Pubitemid 34227114)
5. Bailey ME, Brown RW, Mody DR, et al. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1. Acta Cytol 1996;40:1212-16.
6. Comin CE, Saieva C, Messerini L. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 2007;31:1139-48. (Pubitemid 47207115)
7. Ordóñez NG. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Adv Anat Pathol 2006;13:16-25. (Pubitemid 44357145)
8. Ordóñez NG. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. Am J Clin Pathol 1998;109:85-9. (Pubitemid 28023815)
9. Clement PB. Reactive tumor-like lesions of the peritoneum. Am J Clin Pathol 1995;103:673-6.
10. Clement PB. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol 2007;14:241-60. (Pubitemid 47012362)
11. Clement PB, Young RH. Florid mesothelial hyperplasia associated with ovarian tumors: a potential source of error in tumor diagnosis and staging. Int J Gynecol Pathol 1993;12:51-8. (Pubitemid 23013911)
12. Kerner H, Gaton E, Czernobilsky B. Unusual ovarian, tubal and pelvic mesothelial inclusions in patients with endometriosis. Histopathology 1981;5:277-83. (Pubitemid 11039342)
13. Wilkinson L, De P, Bloxham C. Mesothelial reaction in longstanding Crohn's ileitis simulating papillary mesothelioma. J Clin Pathol 2008;61:1119-21.
14. McCluggage WG, Young RH. Non-neoplastic granulosa cells within ovarian vascular channels: a rare potential diagnostic pitfall. J Clin Pathol 2004;57:151-4. (Pubitemid 38177752)
15. Acikalin MF, Ozalp S, Turan D. Mesothelial pelvic lymph node inclusion in a patient with ovarian microinvasive borderline mucinous tumor: case report with review of the literature. Int J Gynecol Cancer 2007;17:917-21. (Pubitemid 47063325)
16. Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003;43:231-8.
17. Portugal R, Oliva E. Calretinin: diagnostic utility in the female genital tract. Adv Anat Pathol 2009;16:118-24.
18. Donaldson JC, Elliott RC, Kaminsky DB, et al. Psammoma bodies in pleural fluid associated with a mesothelioma: case report. Mil Med 1979;144:476-9. (Pubitemid 9233581)
19. Miyoshi I, Komatsu N, Daibata M, et al. Psammoma bodies in malignant pleural mesothelioma. Intern Med 2007;46:529-30. (Pubitemid 46629957)
20. King JE, Thatcher N, Pickering CAC, et al. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006;48:223-32.
21. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000;19:158-63. (Pubitemid 30212153)
22. Craig JR, Hart WR. Extragenital adenomatoid tumor: evidence for the mesothelial theory of origin. Cancer 1979;43:1678-81. (Pubitemid 9203716)
23. Zhao C, Bratthauer GL, Barner R, et al. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: a study of 160 cases. Am J Surg Pathol 2007;31:255-66. (Pubitemid 46175027)
24. Zhao C, Vinh TN, McManus K, et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 2009;33:354-66.